Axonics, Inc.

Axonics, Inc.verified

AXNX

Price:

$70.98

Market Cap:

$3.63B

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products throu...[Read more]

Industry

Medical - Devices

IPO Date

2018-10-31

Stock Exchange

NASDAQ

Ticker

AXNX

The Enterprise Value as of December 2024 (TTM) for Axonics, Inc. (AXNX) is 3.42B

According to Axonics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.42B. This represents a change of 5.41% compared to the average of 3.25B of the last 4 quarters.

Axonics, Inc. (AXNX) Historical Enterprise Value (quarterly & annually)

How has AXNX Enterprise Value performed in the past?

The mean historical Enterprise Value of Axonics, Inc. over the last ten years is 1.34B. The current 3.42B Enterprise Value has changed 25.47% with respect to the historical average. Over the past ten years (40 quarters), AXNX's Enterprise Value was at its highest in in the September 2024 quarter at 3.35B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

1.34B

Median

1.14B

Minimum

30.94M

Maximum

2.98B

Axonics, Inc. (AXNX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Axonics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.99%

Maximum Annual Enterprise Value = 2.98B

Minimum Annual Increase = -87.85%

Minimum Annual Enterprise Value = 30.94M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.98B10.70%
20222.69B22.16%
20212.20B34.53%
20201.64B153.36%
2019645.91M1.99%
201830.94M-87.85%
2017254.73M-4.74%

Axonics, Inc. (AXNX) Average Enterprise Value

How has AXNX Enterprise Value performed in the past?

The current Enterprise Value of Axonics, Inc. (AXNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.62B

5-year avg

2.03B

10-year avg

1.34B

Axonics, Inc. (AXNX) Enterprise Value vs. Peers

How is AXNX’s Enterprise Value compared to its peers?

Axonics, Inc.’s Enterprise Value is less than Orthofix Medical Inc. (0), greater than NuVasive, Inc. (769.82M), greater than Glaukos Corporation (2.84B), less than Heska Corporation (8.39B), greater than Bruker Corporation (1.26B), less than Integer Holdings Corporation (10.98B), less than CONMED Corporation (5.66B), greater than LivaNova PLC (3.06B), greater than iRhythm Technologies, Inc. (2.87B), greater than OrthoPediatrics Corp. (3.01B), greater than Pulmonx Corporation (520.22M), greater than SI-BONE, Inc. (235.74M), greater than NeuroPace, Inc. (564.83M), greater than Integra LifeSciences Holdings Corporation (390.59M), less than Monogram Orthopaedics, Inc. (3.48B), greater than Nano-X Imaging Ltd. (72.70M), greater than Medtronic plc (383.80M), less than null (131.49B),

Build a custom stock screener for Axonics, Inc. (AXNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axonics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axonics, Inc. (AXNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axonics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Axonics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Axonics, Inc. (AXNX)?

What is the 3-year average Enterprise Value for Axonics, Inc. (AXNX)?

What is the 5-year average Enterprise Value for Axonics, Inc. (AXNX)?

How does the current Enterprise Value for Axonics, Inc. (AXNX) compare to its historical average?